VIP - Vascular Infection Project
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Bordeaux
About this trial
Constitution of a prospective multicentric observational database to study vascular infections, both native, especially aortitis, and vascular graft and endograft infections. Clinical and paraclinical data on medical, surgical, anesthetic and intensive care management will be collected in order to better characterize these infections
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
≥ 18 years-old;
all patients with a vascular infection, either native (aortitis, arteritis) or prosthetic (vascular graft, endograft and/or stent),
oral consent
Disqualifiers
patient under legal protection
Trial population
ents with a vascular infection, either native (aortitis, arteritis) or prosthetic (vascular graft, endograft and/or stent)
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
1,000 Participants
are grouped into 2 trial groupsGroup A: Native vascular infection
Group B: Prosthetic vascular infections
Trial outcomes
Primary outcomes
1
mortality
mortality r
Time frame
Year 1Secondary outcomes
1
mortality
mortality rate
Time frame
Day 30, Year 2, Year 52
morbidity
morbidity rate
Time frame
Year 13
relapse
relapse rates
Time frame
year 1, Year 2, Year 54
reinfection
reinfection rates
Time frame
year 1, Year 2, Year 5Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov